We are live on ! Find out more
HCA icon

HCA Healthcare

1,180 hedge funds and large institutions have $47.7B invested in HCA Healthcare in 2024 Q4 according to their latest regulatory filings, with 148 funds opening new positions, 399 increasing their positions, 468 reducing their positions, and 149 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.52% more ownership

Funds ownership: 61.2%62.72% (+1.5%)

8% more call options, than puts

Call options by funds: $673M | Put options by funds: $624M

1% less first-time investments, than exits

New positions opened: 148 | Existing positions closed: 149

2% less funds holding

Funds holding: 1,2021,180 (-22)

15% less repeat investments, than reductions

Existing positions increased: 399 | Existing positions reduced: 468

26% less capital invested

Capital invested by funds: $64.1B → $47.7B (-$16.4B)

30% less funds holding in top 10

Funds holding in top 10: 4028 (-12)

Holders
1,180
Holders Change
-22
Holders Change %
-1.83%
% of All Funds
15.54%
Holding in Top 10
28
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-30%
% of All Funds
0.37%
New
148
Increased
399
Reduced
468
Closed
149
Calls
$673M
Puts
$624M
Net Calls
+$48.6M
Net Calls Change
+$220M
Name Holding Trade Value Shares
Change
Change in
Stake
UOTTAIMCU
476
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$2.2M +$925K +2,646 +57%
MGP
477
Metis Global Partners
California
$2.18M -$53.1K -152 -2%
TAM
478
Tocqueville Asset Management
New York
$2.17M -$220K -629 -8%
SVWAG
479
Sound View Wealth Advisors Group
Georgia
$2.16M +$186K +531 +8%
NB
480
Norinchukin Bank
Japan
$2.16M +$25.9K +74 +1%
NW
481
NewEdge Wealth
Pennsylvania
$2.15M -$529K -1,515 -17%
EF
482
Empirical Finance
Pennsylvania
$2.13M -$41.6K -119 -2%
TGAM
483
TBH Global Asset Management
Tennessee
$2.13M +$29K +83 +1%
UB
484
Umpqua Bank
Oregon
$2.11M +$112K +320 +5%
OTL
485
Oak Thistle LLC
New York
$2.11M +$2.25M +6,424 +1,043%
Lido Advisors
486
Lido Advisors
California
$2.11M -$521K -1,491 -18%
UWPG
487
Ullmann Wealth Partners Group
Florida
$2.04M -$14.7K -42 -0.6%
BHCM
488
Brevan Howard Capital Management
Jersey
$2.04M -$1.89M -5,416 -44%
CFGS
489
Concourse Financial Group Securities
Alabama
$2.03M -$46.8K -134 -2%
KA
490
Kintegral Advisory
New York
$2.02M -$110K -314 -4%
FRA
491
Frank Rimerman Advisors
California
$1.99M -$46.5K -133 -2%
MYLI
492
Meiji Yasuda Life Insurance
Japan
$1.98M -$6.64K -19 -0.3%
KAS
493
Kestra Advisory Services
Texas
$1.97M +$265K +757 +13%
BCI
494
Brinker Capital Investments
Pennsylvania
$1.97M -$61.5K -176 -3%
OPS
495
Orion Portfolio Solutions
Nebraska
$1.97M -$61.5K -176 -3%
HCCM
496
Hudson Canyon Capital Management
New York
$1.97M
CP
497
CenterBook Partners
Connecticut
$1.96M +$2.28M +6,538 New
BAMCO Inc
498
BAMCO Inc
New York
$1.95M -$4.12M -11,800 -64%
Acadian Asset Management
499
Acadian Asset Management
Massachusetts
$1.9M -$9.22M -26,388 -81%
Focus Partners Wealth
500
Focus Partners Wealth
Massachusetts
$1.9M -$2.28M -6,521 -51%

HCA Hedge Fund Activity: Q4 2024 in Review

1,180 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q4 2024, worth a combined $47.7B — down 26% from $64.1B a quarter earlier.

Sellers outnumbered buyers: 149 funds closed out of HCA and 148 opened new positions — a net loss of 1 holder — while 468 trimmed existing stakes and 399 added.

The largest buyer was Qube Research & Technologies (QRT), adding an estimated $332M. The largest seller was Fidelity Investments, cutting an estimated $513M.

  • 1,180 institutional investors held HCA Healthcare (HCA) as of Q4 2024, down from 1,202 in Q3 2024.
  • Funds reported $47.7B of HCA Healthcare stock for Q4 2024, down 26% quarter-over-quarter.
  • 148 funds opened new HCA Healthcare positions in Q4 2024 and 149 closed out, a net change of -1 holder.
  • The largest HCA Healthcare buyer in Q4 2024 was Qube Research & Technologies (QRT), an estimated $332M added.
  • The largest HCA Healthcare seller in Q4 2024 was Fidelity Investments, an estimated $513M sold.

Based on aggregated 13F filings for Q4 2024.